EUVIMEDEUVIMED entdecken
Crossref

Severe hepatic steatosis promotes increased liver stiffness in the early stages of metabolic dysfunction–associated steatotic liver disease

Takashi Kumada iD, Hidenori Toyoda iD, Sadanobu Ogawa iD, Tatsuya Gotoh iD, Yasuaki Suzuki iD, Katsutoshi Sugimoto iD, Yuichi Yoshida iD, Hidekatsu Kuroda iD, Yoshihiro Kamada iD, Yoshio Sumida iD, Takanori Ito iD, Tomoyuki Akita iD und 1 weitere

Liver International · 2024

DOI: 10.1111/liv.15920 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Takashi Kumada und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Faculty of Nursing, Gifu Kyoritsu University, Gifu, Japan. Hauptthemen laut MEDLINE: Elasticity Imaging Techniques, Disease Progression, Magnetic Resonance Imaging, Liver. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims The predictors of progression from steatosis to more advanced stages of metabolic dysfunction–associated steatotic liver disease (MASLD) remain unclear. We evaluated the association between the quantity of hepatic steatosis and longitudinal changes in liver stiffness measurements (LSMs) using magnetic resonance elastography (MRE) in patients with MASLD.

Methods

We retrospectively analysed patients with MASLD who underwent at least two serial MRE and magnetic resonance imaging–based proton density fat fraction (MRI‐PDFF) examinations at least 1 year apart. Fine‐Gray competitive proportional hazard regression was used to identify LSM progression and regression factors.

Results

A total of 471 patients were enrolled. Factors linked to LSM progression were steatosis grade 3 (MRI‐PDFF ≥17.1%, adjusted hazard ratio [aHR] 2.597; 95% confidence interval [CI] 1.483–4.547) and albumin–bilirubin grade 2 or 3 (aHR 2.790; 95% CI 1.284–6.091), while the only factor linked to LSM regression was % decrease rate of MRI‐PDFF ≥5% (aHR 2.781; 95% CI 1.584–4.883). Steatosis grade 3 correlated with a higher incidence rate of LSM progression than steatosis grade 1 (MRI‐PDFF

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Elasticity Imaging TechniquesDisease ProgressionMagnetic Resonance ImagingLiverFatty LiverHumansMaleFemaleRetrospective StudiesMiddle AgedAgedAdultSeverity of Illness IndexProportional Hazards ModelsNon-alcoholic Fatty Liver Disease

Stichwörter der Autor:innen

LSM (liver stiffness measurement)MASLD (metabolic dysfunction–associated steatotic liver disease)MRE (magnetic resonance elastography)MRI‐PDFF (magnetic resonance imaging–based proton density fat fraction)

Autor:innen und Institutionen

  • Department of Nursing, Faculty of Nursing, Gifu Kyoritsu University, Gifu, Japan.
  • Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Department of Imaging Diagnosis, Ogaki Municipal Hospital, Ogaki, Japan.
  • Department of Gastroenterology, Nayoro City General Hospital, Nayoro, Japan.
  • Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
  • Department of Gastroenterology and Hepatology, Suita Municipal Hospital, Osaka, Japan.

ORCID-Profile: Takashi Kumada, Hidenori Toyoda, Sadanobu Ogawa, Tatsuya Gotoh, Yasuaki Suzuki, Katsutoshi Sugimoto, Yuichi Yoshida, Hidekatsu Kuroda, Yoshihiro Kamada, Yoshio Sumida, Takanori Ito, Tomoyuki Akita, Junko Tanaka

Zitieren

APA

Kumada, T., Toyoda, H., Ogawa, S., Gotoh, T., Suzuki, Y., Sugimoto, K., Yoshida, Y., Kuroda, H., Kamada, Y., Sumida, Y., Ito, T., Akita, T., & Tanaka, J. (2024). Severe hepatic steatosis promotes increased liver stiffness in the early stages of metabolic dysfunction–associated steatotic liver disease. Liver International. https://doi.org/10.1111/liv.15920

Vancouver

Kumada T, Toyoda H, Ogawa S, Gotoh T, Suzuki Y, Sugimoto K, et al. Severe hepatic steatosis promotes increased liver stiffness in the early stages of metabolic dysfunction–associated steatotic liver disease. Liver International. 2024. doi:10.1111/liv.15920

BibTeX
@article{Kumada2024,
  author = {Kumada, Takashi and Toyoda, Hidenori and Ogawa, Sadanobu and Gotoh, Tatsuya and Suzuki, Yasuaki and Sugimoto, Katsutoshi and Yoshida, Yuichi and Kuroda, Hidekatsu and Kamada, Yoshihiro and Sumida, Yoshio and Ito, Takanori and Akita, Tomoyuki and Tanaka, Junko},
  title = {Severe hepatic steatosis promotes increased liver stiffness in the early stages of metabolic dysfunction–associated steatotic liver disease},
  journal = {Liver International},
  year = {2024},
  doi = {10.1111/liv.15920}
}
Kostenlos starten →